5-(4-(4-((1-(4-(2,4-DIOXO-1,3-DIAZINAN-1-YL)-3-METHYLPHENYL)PIPERIDIN-4-YL)METHYL)PIPERAZIN-1-YL)-3-FLUOROANILINO)-3-((3R)-3-(3-METHYL-2-OXOIMIDAZOLIDIN-1-YL)PIPERIDIN-1-YL)-1,2,4-TRIAZINE-6-CARBOXAMIDE
UNII XP8EBD5D8M
Substance Identification & Data
This profile provides standardized clinical and technical data for 5-(4-(4-((1-(4-(2,4-dioxo-1,3-diazinan-1-yl)-3-methylphenyl)piperidin-4-yl)methyl)piperazin-1-yl)-3-fluoroanilino)-3-((3r)-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidin-1-yl)-1,2,4-triazine-6-carboxamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) XP8EBD5D8M.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2955873-30-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C40H52FN13O4 QVYCTHKQEODBDL-SSEXGKCCSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 5-(4-(4-((1-(4-(2,4-dioxo-1,3-diazinan-1-yl)-3-methylphenyl)piperidin-4-yl)methyl)piperazin-1-yl)-3-fluoroanilino)-3-((3r)-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidin-1-yl)-1,2,4-triazine-6-carboxamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.